Acrobiosystems Co.,Ltd. (SHE:301080)

China flag China · Delayed Price · Currency is CNY
49.66
+0.80 (1.64%)
At close: Jul 11, 2025, 2:57 PM CST
108.22%
Market Cap 8.33B
Revenue (ttm) 685.51M
Net Income (ttm) 133.74M
Shares Out 167.67M
EPS (ttm) 0.80
PE Ratio 62.41
Forward PE 52.20
Dividend 0.57 (1.15%)
Ex-Dividend Date Jul 11, 2025
Volume 3,301,030
Average Volume 4,189,087
Open 48.20
Previous Close 48.86
Day's Range 48.18 - 50.37
52-Week Range 22.36 - 72.85
Beta 1.00
RSI 64.95
Earnings Date Aug 22, 2025

About Acrobiosystems

Acrobiosystems Co.,Ltd. engages in the development and manufacture of recombinant proteins, antibodies, and other biological reagents for pharmaceutical and biotechnology companies, and scientific research institutions. The company has a collaboration with Diagnostic Biochips Inc for neurological drug discovery and commercialization. The company was founded in 2010 and is based in Beijing, China. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2010
Employees 869
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 301080
Full Company Profile

Financial Performance

In 2024, Acrobiosystems's revenue was 645.02 million, an increase of 18.65% compared to the previous year's 543.65 million. Earnings were 123.83 million, a decrease of -19.38%.

Financial Statements

News

There is no news available yet.